Comparison of Nutrition-Related Adverse Events and Clinical Outcomes Between ICE (Ifosfamide, Carboplatin, and Etoposide) and MCEC (Ranimustine, Carboplatin, Etoposide, and Cyclophosphamide) Therapies as Pretreatment for Autologous Peripheral Blood Stem Cell Transplantation in Patients with Malignant Lymphoma

Takashi Aoyama; Osamu Imataki; Hidekazu Arai; Tetsuo Kume; Hitomi Shiozaki; Naomi Katsumata; Mariko Mori; Keiko Ishide; Takashi Ikeda

doi:10.12659/MSMBR.908113

05 February 2018 : Original article

Comparison of Nutrition-Related Adverse Events and Clinical Outcomes Between ICE (Ifosfamide, Carboplatin, and Etoposide) and MCEC (Ranimustine, Carboplatin, Etoposide, and Cyclophosphamide) Therapies as Pretreatment for Autologous Peripheral Blood Stem Cell Transplantation in Patients with Malignant Lymphoma

Takashi Aoyama^{ABCDEFG 1*}, Osamu Imataki^{E 2}, Hidekazu Arai^{E 3}, Tetsuo Kume^{E 4}, Hitomi Shiozaki^{B 1}, Naomi Katsumata^{B 1}, Mariko Mori^{B 1}, Keiko Ishide^{B 5}, Takashi Ikeda^{E 6}

DOI: 10.12659/MSMBR.908113

Med Sci Monit Basic Res 2018; 24:31-39

Authors information Article notes Copyright and License information

Related articles Order reprints Share article Share by email

View HTML version

Back to the Article

Your Privacy